| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |